Tuesday, November 5, 2019 - 13:25
Sofia, Bulgaria, November 5, 2019 - Sopharma AD notifies that for October 2019 the Company recorded an increase in sales of 40% compared to the same month of 2018, incl. 30% increase in sales for the domestic market and 48% increase in export sales.
In the first ten months of 2019 the revenues from sales of production increased by 6% compared to the same period of 2018, incl. 4% decrease in domestic sales and 13% increase in export sales.